jaeil at mdanderson dot org
Jae-Il received BS and MS from Korea University in 2001 (Dr. Sung-Gil Chi lab). Then, he completed Ph.D. training (2002~2006) under the guidance of Dr. Pierre D. McCrea with a research interest in Wnt signaling. After postdoctoral training at Stanford University School of Medicine (Dr. Steven E. Artandi) (2006~2010), Jae-Il joined MD Anderson Cancer Center as Assistant Professor in 2010 and got tenured/promoted to Associate Professor in 2016.
His research program is to unveil how stem cells contribute to various physiologic and pathologic conditions including tissue homeostasis, regeneration, and tumorigenesis, which may lead to developing disease modeling systems and therapeutic applications in regenerative medicine and cancer.
Hobby: listening and playing 80, 90 rocks, cycling. Zodiac: Libra
I am interested in (1) cancer and (2) cancer treatment. During Ph.D. training, I studied tumorigenesis using Drosophila melanogaster as a genetic model system. Now I switch the gear to mouse genetics and am happily exploring the molecular and cellular mechanisms of cancers. My current research mainly focuses on PAF oncogene-associated lung and colorectal cancer. My ultimate goal is to gain the insights into the fundamental mechanisms of cancer to ‘erase cancer’. Research interest: tissue stem cell activation, tissue regeneration, tumor-initiating cells, colorectal and lung cancer, mouse models.
Sohee has established various genetically engineered mouse models including knock-in, knock-out, and transgenic mice from the conventional embryonic stem cell targeting. Zodiac: Taurus. Research area: genetically engineered mouse models, embryonic stem cells
Jie graduated from medical college in China. He got the master's degree in human anatomy and histo-embryology. He has been a Lecturer in human anatomy and histology for ten years. In addition to teaching, he studied on tumor immunology. After that, he joined MD Anderson Cancer Center as a histologist in the Department of Pathology and Experimental Radiation Oncology. Research area: histopathology.
YuanJian Huang, MD
Yuanjian received his M.D. degree from Huazhong University of Science and Technology (HUST) in 2016. He is now working as a colorectal surgeon in The First Affiliated Hospital of Nanjing Medical University. He has been working on establishing a new drug-delivery system to target colorectal cancer and elucidating the mechanisms of gene regulation by ncRNAs in the Wnt/β-catenin signaling for colorectal cancer. At MD Anderson Cancer, he begins to develop his expertise in nuclear actin dynamics and tumorigenesis by developing genetically engineered mouse models. His goal is to actualize himself, trying to make some contributions to erasing cancer. Hobby: Basketball, DOTA2, movies. Zodiac: Sagittarius
szhang23 at mdanderson dot org
I received my PhD degree in Biology from Shanghai Jiao Tong University in 2018. During PhD training, I studied the correlation between deubiquitinase USP13 and MCL1 stability and sensitivity to BH3 mimetic inhibitors in lung cancer and ovarian cancer. My current work focuses on TMEM9 (Transmembrane Protein 9)
regulation in tumorigenesis and cancer progression. In my free time I enjoy movies, music and spending time with my family.
Youn-Sang Jung, PhD, Assistant Professor, Chung-Ang University, Seoul, Korea
Christopher Cervantes, PhD student (UT-Southwestern)
Biyun Zheng, MD, PhD (Fujian Medical University Union Hospital)
Hanna Suh, DVM, PhD (Korea Institute of Toxicology)
Alaa Mohamed Tamim (MD Anderson)
Sung-Ho Lee, PhD
Isuru Somawardana (Rice)
Joan Shang (MD/PhD candidate, Icahn School of Medicine at Mount Sinai)
Esther M. Lien
Christopher Ng (UTMB)
Sunhye Lee, PhD (USC)
Jung-In Yang, MD (Albert Einstein)
Andrea M. Schneider (Penn State)
Han-Cheon Kim, PhD
Moonsup Lee, PhD (NIH-NCI)
Xin Wang, PhD (MD Anderson)
In Young Park
Hae-Yun Jung, PhD (UCSD)
Seung-Hyo Lee, Associate Professor (KAIST)
Bum-Joon Park, Professor (Busan University)